Dr. Usman's Cardiology Notes

Echocardiographic Signs of Pulmonary Hypertension (PH) 1. Elevated Pulmonary Artery Systolic Pressure (PASP) Most important screening parameter. Estimated from TR Jet Velocity: PASP = 4(V_{TR})^2 + RAP TR velocity >2.8–3.4 m/s suggests PH Higher velocity → higher probability of PH --- 2. Right Ventricular (RV) Changes RV dilatation RV hypertrophy (RV free wall >5 mm) Reduced RV systolic function RV pressure overload pattern Severe PH: RV larger than LV Reduced TAPSE Reduced RV FAC --- 3. Interventricular Septal Flattening Due to RV pressure overload. D-shaped LV in PSAX Systolic flattening → pressure overload Diastolic flattening → volume overload --- 4. Right Atrial Enlargement Enlarged RA area Dilated IVC with reduced collapse Suggests elevated right-sided pressures. --- 5. Pulmonary Artery Abnormalities Dilated main pulmonary artery PA diameter >25 mm Early systolic notching on RVOT Doppler --- 6. Shortened Pulmonary Acceleration Time (PAT) RVOT PW Doppler: PAT <105 ms s...

  TAVI vs SAVR: A Complete Clinical Comparison for Aortic Stenosis --- Introduction Severe aortic stenosis (AS) is a life-threatening condition with very high mortality if untreated. Valve replacement is the only definitive therapy. Two major approaches exist: TAVI (Transcatheter Aortic Valve Implantation) SAVR (Surgical Aortic Valve Replacement) Over the past decade, TAVI has revolutionized management, but SAVR remains crucial in selected patients. Decision-making is now individualized and guided by a Heart Team approach. --- Basic Definitions TAVI A minimally invasive catheter-based procedure in which a bioprosthetic valve is implanted via femoral (or alternative) access without open-heart surgery. SAVR A conventional open-heart surgery involving sternotomy, cardiopulmonary bypass, and surgical replacement of the aortic valve (mechanical or bioprosthetic). --- Indications (Guideline-Based) TAVI Preferred Age >80 years or life expectancy <10 years High or prohibitive surgica...

  Echocardiographic Evaluation of Pulmonary Regurgitation (PR) --- 1. 2D Echocardiography (Structural Assessment) Assess pulmonary valve morphology (normal, dysplastic, post-surgical, infective) Evaluate right ventricle (RV): RV dilatation (chronic PR hallmark) RV systolic function Look for: Dilated main pulmonary artery Associated congenital lesions (e.g., repaired TOF) --- 2. Color Doppler Assessment Visualize diastolic regurgitant jet from pulmonary artery → RVOT Assess: Jet width Jet length Vena contracta width Severe PR: Broad jet filling RVOT Mild PR: Thin, short jet near valve --- 3. Continuous Wave (CW) Doppler Key parameters: Density of signal → dense = severe Deceleration slope → steep slope = severe PR Early termination of flow Pressure Half-Time (PHT) Short PHT → more severe PR Typical interpretation: PHT < 100 ms → Severe PR 100–200 ms → Moderate > 200 ms → Mild --- 4. Pulsed Wave (PW) Doppler Sample in main pulmonary artery / branch PAs Findings: Diastolic flow ...

  How to Start Statins – A Quick Clinical Guide Introduction Statins remain the cornerstone of lipid-lowering therapy and cardiovascular risk reduction. By inhibiting HMG-CoA reductase, they significantly reduce LDL cholesterol and prevent atherosclerotic cardiovascular disease (ASCVD). Correct patient selection, appropriate intensity, and proper follow-up are essential for optimal outcomes. --- What Are Statins? Statins are lipid-lowering agents that: Inhibit HMG-CoA reductase Reduce LDL cholesterol Stabilize atherosclerotic plaques Decrease risk of MI, stroke, and cardiovascular death --- When to Start Statins (Key Indications) 1. Established ASCVD Previous myocardial infarction Ischemic stroke Peripheral arterial disease → Start high-intensity statin 2. LDL ≥190 mg/dL Suggests familial hypercholesterolemia → Start high-intensity statin 3. Diabetes Mellitus (Age 40–75) LDL ≥70 mg/dL → Start moderate-intensity statin → Consider high-intensity if multiple risk factors 4. High 10-Ye...

 The Carpentier classification system of mitral regurgitation is based on leaflet motion

  PISA Method for Aortic Regurgitation (AR) Concept PISA (Proximal Isovelocity Surface Area) is based on the principle that blood accelerates toward a regurgitant orifice forming hemispheric shells of equal velocity. By measuring these, we can quantify regurgitant flow. --- Key Formula EROA = \frac{2\pi r^2 \cdot V_{alias}}{V_{max}} --- Parameters r = PISA radius (cm) V_alias = aliasing velocity (cm/s) Vmax = peak AR velocity by CW Doppler (cm/s) --- Regurgitant Volume RVol = EROA \times VTI_{AR} --- Step-by-Step Technique 1. Use apical 5-chamber or long-axis view 2. Apply color Doppler over aortic valve 3. Lower Nyquist limit (~30–40 cm/s) 4. Zoom on LVOT/aortic valve 5. Identify flow convergence (hemisphere) 6. Measure radius (r) from orifice to aliasing line 7. Record Vmax and VTI using CW Doppler 8. Apply formulas --- Severity Cutoffs (Guideline-Based) Severity EROA (cm²) Regurgitant Volume (mL) Mild <0.10 <30 Moderate 0.10–0.29 30–59 Severe ≥0.30 ≥60 --- Important Limita...

NOBLE 10-year outcomes of PCI vs CABG in left main disease Long-term evidence comparing PCI and CABG for unprotected left main coronary disease has been limited and sometimes conflicting. The 10-year results from the NOBLE trial now provide important clarity on all-cause mortality outcomes with both revascularisation strategies. #InterventionalCardiology #clinicaltrials #clinicalresearch